Fund Overview
ETF
Nippon India Nifty Pharma ETF
Ticker: PHARMABEESUnderlying Index: Nifty PharmaISIN: INF204KC1089
26.2714.06% (1Y)
End of Day NAV as on Jul 24, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 Companies |
| Market Cap Focus | Multi / Flexi Cap |
| Std Deviation (1 yr) | 0.90% |
| P/E | 48.42 |
| P/B | 6.39 |
| Div Yield | 0.63% |
| Down from 52w High | 3.60% |
| Up from 52w Low | 22.41% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 20 |
| Market Cap Focus | Multi / Flexi Cap |
| P/E | 48.42 |
| P/B | 6.39 |
| Div Yield | 0.63% |
| Down from 52w High | 3.60% |
| Up from 52w Low | 22.41% |
| Std Deviation (1 yr) | 0.90% |
Fund Parameters
| AUM (Cr) | 1,570 |
| Base Expense Ratio | 0.18% |
| Tracking Error | 0.02% |
| All-In-Cost | 0.27% |
| Inception Date | 06 Jul 2021 |
| Scheme Option - Type | Growth - Open ended scheme |
| Latest Price | 26.28 |
| NAV Gap | 0.04% |
| 1M Average NAV Gap | 0.07% |
| Daily Volume | 28,46,354 |
| 1M Average Daily Volume | 62,46,375 |
| 1M Average Daily Turnover (Cr) | 16.5 |
Native Score
| AUM (Cr) | 1,570 |
| Base Expense Ratio | 0.18% |
| Tracking Error | 0.02% |
| All-In-Cost | 0.27% |
| Inception Date | 06 Jul 2021 |
| Scheme Option - Type | Growth - Open ended scheme |
| ETF Market Data | |
| Latest Price | 26.28 |
| NAV Gap | 0.04% |
| 1M Avg NAV Gap | 0.07% |
| Daily Volume | 28,46,354 |
| 1M Avg Daily Volume | 62,46,375 |
| 1M Avg Daily Turnover | 16.5 |
| Native Score | |
Loading
Loading mutual funds data...
Sectoral Allocation
Fund Holdings
Market Cap Classification
Advanced Ratios
| Alpha | 0.00 |
| Beta | 1.00 |
| Sharpe Ratio | 0.05 |
| Sortino Ratio | 0.09 |
| Treynor Ratio | 0.05 |
| Information Ratio | 0.02 |
| Upside Capture | 99.81% |
| Downside Capture | 99.63% |
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | Nifty 500 |
| Weightage? | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
| Factor Basis | Sector/Theme |
| Universe | Nifty 500 |
| Weightage | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
Fund • Last updated: 7/26/2026